{"id":115403,"date":"2020-11-04T14:15:06","date_gmt":"2020-11-04T22:15:06","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/11\/perkinelmer-snaps-up-crispr-provider-horizon-discovery-in-383m-deal"},"modified":"2020-11-04T14:15:06","modified_gmt":"2020-11-04T22:15:06","slug":"perkinelmer-snaps-up-crispr-provider-horizon-discovery-in-383m-deal","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/11\/perkinelmer-snaps-up-crispr-provider-horizon-discovery-in-383m-deal","title":{"rendered":"PerkinElmer snaps up CRISPR provider Horizon Discovery in $383M deal"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/perkinelmer-snaps-up-crispr-provider-horizon-discovery-in-383m-deal.jpg\"><\/a><\/p>\n<p>PerkinElmer has moved to expand its life sciences portfolio with CRISPR and gene editing offerings by snapping up the cell engineering specialist Horizon Discovery.<\/p>\n<p>The $383 million, all-cash deal will add gene modulation tools that\u2014in combination with its own work in applied genomics solutions\u2014aims to provide next-generation research tools and the customized cell lines necessary for developers of new targeted therapies, and broaden PerkinElmer\u2019s partnership work with academic researchers and the biopharma industry.<\/p>\n<p>The Cambridge, U.K.-based Horizon, with about 400 employees worldwide with offices in the U.S. and Japan, provides genetic base editing technologies for living cell models using CRISPR reagents, as well as gene modulation products using RNA interference methods.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PerkinElmer has moved to expand its life sciences portfolio with CRISPR and gene editing offerings by snapping up the cell engineering specialist Horizon Discovery. The $383 million, all-cash deal will add gene modulation tools that\u2014in combination with its own work in applied genomics solutions\u2014aims to provide next-generation research tools and the customized cell lines necessary [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1902,11,412],"tags":[],"class_list":["post-115403","post","type-post","status-publish","format-standard","hentry","category-bioengineering","category-biotech-medical","category-genetics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/115403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=115403"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/115403\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=115403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=115403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=115403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}